Search results for "Diagnosis of schizophrenia"

showing 10 items of 10 documents

Design and validation of a brief scale for cognitive evaluation in people with a diagnosis of schizophrenia (BCog‐S)

2019

WHAT IS KNOWN ON THE SUBJECT?: Schizophrenia is often related to cognitive deficits. Mental health nurses are involved in health promotion, prevention, treatment and rehabilitation in schizophrenia. However, the nursing literature addressing cognitive rehabilitation from schizophrenia is very limited. Cognition and its domains (communication, information processing, attentiveness, concentration, orientation, memory and calculation skills) are established by the Nursing Outcomes Classification (NOC), but they are difficult to measure. WHAT THE PAPER ADDS TO EXISTING KNOWLEDGE?: We present a new standardized cognitive assessment to be administered by nurses to people diagnosed with schizophre…

AdultMaleAdolescentPsychometricsmedicine.medical_treatmentSchizophrenia (object-oriented programming)Psychiatric NursingSchizoaffective disorderNeuropsychological TestsYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansCognitive DysfunctionProspective StudiesCognitive rehabilitation therapyCognitive evaluation theoryRehabilitation030504 nursingCognitionMiddle Agedmedicine.disease030227 psychiatryNursing Outcomes ClassificationPsychotic DisordersSchizophreniaFemalePshychiatric Mental Health0305 other medical sciencePsychologyClinical psychologyDiagnosis of schizophreniaJournal of Psychiatric and Mental Health Nursing
researchProduct

Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFI…

2013

Abstract Objective Predicting response to antipsychotic treatment might optimize treatment strategies in early phases of schizophrenia. We aimed to investigate sociodemographic, premorbid and clinical predictors of response to antipsychotic treatment after a first episode of non-affective psychosis. Method 375 (216 males) patients with a diagnosis of non affective psychosis entered the study. The main outcome measure was clinical response at 6 weeks and variables at baseline were evaluated as predictors of response. ANOVA for continuous and chi-square for categorical data were used to compare responders and non-responders. Multivariate logistic regression was used to establish a prediction …

AdultMalePsychosismedicine.medical_specialtyAdolescentLogistic regressionCohort StudiesYoung AdultPredictive Value of TestsOutcome Assessment Health CaremedicineHumansFamily historyPsychiatryBiological PsychiatryRetrospective StudiesPharmacologyFirst episodePsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseLogistic ModelsPsychotic DisordersSchizophreniaSpainCohortdupFemalePsychologyDiagnosis of schizophreniaAntipsychotic AgentsProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year …

2013

Real-world functional deficits are common and persistent in individuals with psychosis. Cognitive deficits have been shown to compromise functioning. We aimed to study the predictive values of premorbid, sociodemographic, and baseline clinical and neurocognitive factors on long-term functional outcome for individuals with first episode non-affective psychosis. We failed to demonstrate a significant relationship between cognitive deficits at baseline and functional disability at 3 year follow-up. Diagnosis of schizophrenia (OR=2.457, p=0.011), shorter education (OR=1.177, p=0.005) and poor premorbid social adjustment (OR=1.628, p=0.013) emerged as the strongest predictors for the 114 subject…

AdultMalePsychosismedicine.medical_specialtyLongitudinal studyAdolescentNeuropsychological TestsOutcome (game theory)Disability EvaluationYoung AdultPredictive Value of TestsmedicineHumansLongitudinal StudiesPsychiatryBiological PsychiatryRetrospective StudiesFirst episodeCognitionMiddle AgedPrognosismedicine.diseasePsychiatry and Mental healthLogistic ModelsPsychotic DisordersSocioeconomic FactorsSchizophreniaFemaleCognition DisordersPsychologyNeurocognitiveAntipsychotic AgentsDiagnosis of schizophreniaPsychiatry Research
researchProduct

Personality disorders among the relatives of schizophrenia patients.

1994

In light of current linkage studies in schizophrenia, research on the "schizophrenia spectrum" deserves increased attention for an exact determination of the affected phenotype: Those disorders that have a much higher prevalence among biological relatives of schizophrenia patients are supposed to share common etiological factors with "core" schizophrenia. However, there is controversy over which of the DSM-III-R personality disorders should be included in the spectrum. In a controlled family study of inpatients with a DSM-III-R diagnosis of schizophrenia (n = 101), schizophreniform and schizoaffective disorders (n = 69), and unipolar major depression (n = 160), familial rates of personality…

AdultMalemedicine.medical_specialtyGenetic Linkagemedia_common.quotation_subjectPersonality Assessmentbehavioral disciplines and activitiesPersonality DisordersSchizotypal Personality DisorderSchizoid personality disorderRisk Factorsmental disordersmedicinePersonalityHumansPsychiatrymedia_commonPsychiatric Status Rating ScalesDepressive DisorderModels Geneticmedicine.diseaseSchizotypal personality disorderPersonality disordersPsychiatry and Mental healthPhenotypePsychotic DisordersSchizophreniaParanoid personality disorderSchizophreniaFemaleSchizophrenic PsychologyPersonality Assessment InventoryPsychologyDiagnosis of schizophreniaClinical psychologySchizophrenia bulletin
researchProduct

Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone p…

2018

BACKGROUND Long-acting injectable (LAI) antipsychotics can improve medication adherence and reduce hospitalisation rates compared with oral treatments. Paliperidone palmitate (PAL) and aripiprazole monohydrate (ARI) LAI treatments were associated with improvements in global functioning in patients with schizophrenia. OBJECTIVE The objective of this study was to assess the predictive factors of better overall functioning in patients with chronic schizophrenia and schizoaffective disorder treated with PAL and ARI. METHOD Enrolled were 143 (97 males, 46 females, mean age 38.24 years, SD = 12.65) patients with a diagnosis of schizophrenia or schizoaffective disorder, whom we allocated in two gr…

AdultMalemedicine.medical_specialtyaripiprazole monohydrate; global assessment of functioning; long-acting injectable antipsychotics; paliperidone palmitate; schizoaffective disorder; schizophrenia; neurology; neurology (clinical); psychiatry and mental health; pharmacology (medical)Global Assessment of FunctioningAripiprazoleSchizoaffective disorderPharmacyOutcome Assessment (Health Care)03 medical and health sciencesYoung Adult0302 clinical medicineglobal assessment of functioningInternal medicineOutcome Assessment Health CarePaliperidone PalmitatemedicineHumansPharmacology (medical)aripiprazole monohydratearipiprazole monohydrate; global assessment of functioning; long-acting injectable antipsychotics; paliperidone palmitate; schizoaffective disorder; schizophrenia; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Schizophrenia; Young Adult; Outcome Assessment (Health Care)Paliperidone Palmitatebusiness.industrylong-acting injectable antipsychoticsMiddle Agedschizoaffective disordermedicine.disease030227 psychiatryPsychiatry and Mental healthNeurologyPsychotic DisordersSchizophreniaDelayed-Action PreparationsSettore SECS-P/03 - Scienza delle FinanzeSchizophreniaChronic schizophreniaAripiprazoleFemaleNeurology (clinical)business030217 neurology & neurosurgeryDiagnosis of schizophreniamedicine.drugAntipsychotic AgentsHuman psychopharmacology
researchProduct

Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives

2010

"Cognitive impairment has been recognized since the earliest descriptions of schizophrenia as a core feature of the illness and different programmes have been developed to remediate these deficits. In all likelihood it is important for compliance and adherence to treatment that not only the patients but also their relatives be aware of the patients; cognitive deficits. Sixty-two patients with a diagnosis of schizophrenia and, for each one of them, one family member and an informant from the medical staff, were recruited and administered the Schizophrenia Cognition Rating Scale (SCoRS) ratings. Patients were tested for cognitive deficits with a neuropsychological battery and their performanc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentNeuropsychological TestsExecutive FunctionmedicineHumansFamilyCognitive skillFirst-degree relativesPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesRehabilitationCognitionAwarenessmedicine.diseaseExecutive functionsPsychiatry and Mental healthCognitive remediation therapySchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersDiagnosis of schizophreniaClinical psychology
researchProduct

Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries

2018

Background: People with schizophrenia engage in low levels of physical activity (PA). However, few large-scale studies have investigated the factors that may influence PA participation in individuals with psychosis and data from low- and middle-income countries (LMICs) is especially scarce. Thus, we investigated PA correlates in a large sample of people with a psychosis diagnosis across 47 LMICs. Methods: Cross-sectional data from the World Health Survey, restricting to those with a self-reported lifetime diagnosis of schizophrenia/psychotic disorder, was analyzed. PA was assessed by the International Physical Activity Questionnaire (IPAQ) and participants were dichotomized into those that …

MaleHealth BehaviorPsychological intervention*PsychosisGlobal Health0302 clinical medicine*Developing countries/dk/atira/pure/subjectarea/asjc/2800/2803Developing countrie*ExerciseMobilityPsychiatry/dk/atira/pure/subjectarea/asjc/2700/2738*Physical activityPsychiatry and Mental healthSchizophreniaPsychiatry and Mental HealthMarital statusAnxietyFemaleBiological psychiatrymedicine.symptomPsychologyPsychosismedicine.medical_specialtyDeveloping countries; Exercise; Mobility; Physical activity; Psychiatry; Psychosis; Schizophrenia; Psychiatry and Mental Health; Biological PsychiatryPsychosiDeveloping countries03 medical and health sciencesmedicineHumansPsychiatryExerciseBiological PsychiatryPhysical activity*SchizophreniaOdds ratiomedicine.diseasePsychosisHealth Surveys030227 psychiatryCross-Sectional StudiesPsychotic DisordersSocioeconomic FactorsSchizophrenia*Psychiatry*Mobility030217 neurology & neurosurgeryDemographyDiagnosis of schizophrenia
researchProduct

Classification of Schizophrenia Patients and Healthy Controls Using ICA of Complex-Valued fMRI Data and Convolutional Neural Networks

2019

Deep learning has contributed greatly to functional magnetic resonance imaging (fMRI) analysis, however, spatial maps derived from fMRI data by independent component analysis (ICA), as promising biomarkers, have rarely been directly used to perform individualized diagnosis. As such, this study proposes a novel framework combining ICA and convolutional neural network (CNN) for classifying schizophrenia patients (SZs) and healthy controls (HCs). ICA is first used to obtain components of interest which have been previously implicated in schizophrenia. Functionally informative slices of these components are then selected and labelled. CNN is finally employed to learn hierarchical diagnostic fea…

medicine.diagnostic_testbusiness.industryComputer scienceDeep learningSchizophrenia (object-oriented programming)05 social sciencesPattern recognitionmedicine.diseaseAuditory cortexConvolutional neural networkIndependent component analysis050105 experimental psychology03 medical and health sciences0302 clinical medicineSchizophreniamedicine0501 psychology and cognitive sciencesArtificial intelligencebusinessFunctional magnetic resonance imaging030217 neurology & neurosurgeryDefault mode networkDiagnosis of schizophrenia
researchProduct

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia

2013

Giuseppe Battaglia,1,3 Marianna Alesi,2 Michele Inguglia,4 Michele Roccella,2 Giovanni Caramazza,3 Marianna Bellafiore,1,3 Antonio Palma1,3 1Department of Law, Social and Sport Science, University of Palermo, Palermo, Italy; 2Department of Psychology, University of Palermo, Palermo Italy; 3Regional Sports School of CONI Sicilia, Sicily, Italy; 4Local Health of Palermo, Palermo, Italy Abstract: Physical activity is an important aspect of good health for everyone; it is even more important for psychiatric patients who usually live an unhealthy lifestyle. In recent years, there has been growing focus on the use of soccer as a vehicle to improve the health of subjects with severe mental illness…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentpsychotic subjectsmedicine.medical_treatmentNeurosciences. Biological psychiatry. NeuropsychiatrySettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneMedicineRC346-429schizophrenia mental illness psychotic subjects sport exercise soccerAntipsychoticBiological PsychiatryOriginal ResearchSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportiveexercisebusiness.industryAnthropometryMental illnessmedicine.diseasemental illnesssoccerSettore MED/39 - Neuropsichiatria InfantileschizophreniaPsychiatry and Mental healthAdd on treatmentSprintPhysical therapyNeurology. Diseases of the nervous systemmedicine.symptomsportbusinesshuman activitiesBody mass indexWeight gainRC321-571Diagnosis of schizophreniaNeuropsychiatric Disease and Treatment
researchProduct

P-1275 - Insight change in schizophrenia: a SMS-based approach

2012

Introduction Many patients with schizophrenia are unaware of the symptoms and consequences of their illness. Poor insight has been associated with medication non-adherence, frequent relapses, and poor prognosis. Objective To assess the effect of daily Short Message Service (SMS) reminders on patients’ insight. Methods A multicenter, prospective, randomized, controlled study was conducted. Outpatients with at least 18 years old, diagnosis of schizophrenia (DSM-IV), and adherence problems (at least one affirmative answer Morisky Green questionnaire) were included. Participants were randomized to receive a daily SMS reminder on their cell phone to take their medication in the following 3 month…

medicine.medical_specialtyPoor prognosisStandard of carebusiness.industryMean ageIntervention groupmedicine.diseaseMean differencePsychiatry and Mental healthSchizophreniaIntervention (counseling)Physical therapyMedicinebusinessPsychiatryDiagnosis of schizophreniaEuropean Psychiatry
researchProduct